Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Oscar Health Q4 2023 GAAP EPS $(0.66) Beats $(0.73) Estimate, Sales $1.43B Beat $1.42B Estimate

Author: Benzinga Newsdesk | February 07, 2024 05:31pm
Oscar Health (NYSE:OSCR) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.73) by 9.59 percent. The company reported quarterly sales of $1.43 billion which beat the analyst consensus estimate of $1.42 billion by 0.83 percent. This is a 43.90 percent increase over sales of $995.13 million the same period last year.

Posted In: OSCR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist